Article
Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease.
Gut - 1 Feb 2014
Gutiérrez Ana, Scharl Michael, Sempere Laura, Holler Ernst, Zapater Pedro, Almenta Isabel, González-Navajas José M, Such José, Wiest Reiner, Rogler Gerhard, Francés Rubén
Abstract excerpt
OBJECTIVE: The aetiology of Crohn's disease (CD) has been related to nucleotide-binding oligomerisation domain containing 2 (NOD2) and ATG16L1 gene variants. The observation of bacterial DNA translocation in patients with CD led us to hypothesise that this process may be facilitated in patients with NOD2/ATG16L1-variant genotypes, affecting the efficacy of anti-tumour necrosis factor (TNF) therapies. DESIGN: 179...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
